3rd Glioblastoma Drug Development Summit
Evvnt Promotion / evvnt
Archiv
18.01.2022 - 20.01.2022 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 8:00 AM - 5:40 PM
Kongressthemen
Together we will increase the length and quality of patient survival from diagnosis.
The 3rd Glioblastoma Drug Development Summit is the only industry led forum for large pharma, biotech and academic KOLs to unite under the common goal of accelerating the practical translation and clinical development of meaningful therapies for the treatment of glioblastoma.
Together we will increase the length and quality of patient survival from diagnosis.
The 3rd Glioblastoma Drug Development Summit is the only industry led forum for large pharma, biotech and academic KOLs to unite under the common goal of accelerating the practical translation and clinical development of meaningful therapies for the treatment of glioblastoma.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anfragen und Anmeldung:
https://go.evvnt.com/882097-2?pid=4832
Frau Ellie Saunders
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
